Jennison Associates’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-21,575
| Closed | -$3.3M | – | 744 |
|
|
2021
Q1 | $3.3M | Hold |
21,575
| – | – | ﹤0.01% | 505 |
|
|
2020
Q4 | $3.37M | Buy |
+21,575
| New | +$2.77M | ﹤0.01% | 477 |
|
|
2020
Q3 | – | Sell |
-33,182
| Closed | -$3.58M | – | 711 |
|
|
2020
Q2 | $3.72M | Sell |
33,182
-326,536
| -91% | -$34.7M | ﹤0.01% | 442 |
|
|
2020
Q1 | $32.3M | Sell |
359,718
-1,503,312
| -81% | -$148M | 0.04% | 192 |
|
|
2019
Q4 | $201M | Sell |
1,863,030
-181,059
| -9% | -$19.4M | 0.2% | 66 |
|
|
2019
Q3 | $200M | Sell |
2,044,089
-6,969,813
| -77% | -$786M | 0.21% | 60 |
|
|
2019
Q2 | $1.18B | Sell |
9,013,902
-1,227,555
| -12% | -$158M | 1.17% | 25 |
|
|
2019
Q1 | $1.38B | Buy |
10,241,457
+1,512,545
| +17% | +$188M | 1.37% | 23 |
|
|
2018
Q4 | $850M | Buy |
8,728,912
+101,376
| +1% | +$12M | 0.95% | 31 |
|
|
2018
Q3 | $1.2B | Buy |
8,627,536
+2,599,414
| +43% | +$326M | 1.11% | 26 |
|
|
2018
Q2 | $748M | Sell |
6,028,122
-1,459,471
| -19% | -$171M | 0.73% | 41 |
|
|
2018
Q1 | $835M | Buy |
7,487,593
+2,466,428
| +49% | +$295M | 0.83% | 41 |
|
|
2017
Q4 | $600M | Sell |
5,021,165
-311,471
| -6% | -$37.9M | 0.59% | 46 |
|
|
2017
Q3 | $748M | Buy |
5,332,636
+4,682,336
| +720% | +$636M | 0.77% | 37 |
|
|
2017
Q2 | $79.1M | Sell |
650,300
-8,976,179
| -93% | -$1.04B | 0.08% | 198 |
|
|
2017
Q1 | $1.17B | Buy |
9,626,479
+1,350,652
| +16% | +$174M | 1.25% | 21 |
|
|
2016
Q4 | $1.01B | Buy |
8,275,827
+1,138,592
| +16% | +$139M | 1.13% | 25 |
|
|
2016
Q3 | $875M | Buy |
7,137,235
+43,840
| +0.6% | +$5.64M | 0.94% | 31 |
|
|
2016
Q2 | $828M | Sell |
7,093,395
-216,732
| -3% | -$30.8M | 0.91% | 32 |
|
|
2016
Q1 | $1.02B | Sell |
7,310,127
-35,897
| -0.5% | -$5.27M | 1.07% | 27 |
|
|
2015
Q4 | $1.4B | Buy |
7,346,024
+481,031
| +7% | +$84M | 1.38% | 18 |
|
|
2015
Q3 | $1.07B | Buy |
6,864,993
+913,030
| +15% | +$167M | 1.1% | 23 |
|
|
2015
Q2 | $1.08B | Buy |
5,951,963
+711,725
| +14% | +$123M | 0.99% | 26 |
|
|
2015
Q1 | $908M | Sell |
5,240,238
-553,113
| -10% | -$100M | 0.83% | 33 |
|
|
2014
Q4 | $1.07B | Sell |
5,793,351
-2,589,663
| -31% | -$480M | 1% | 26 |
|
|
2014
Q3 | $1.39B | Buy |
8,383,014
+234,768
| +3% | +$38.6M | 1.29% | 12 |
|
|
2014
Q2 | $1.27B | Sell |
8,148,246
-232,924
| -3% | -$36.8M | 1.18% | 15 |
|
|
2014
Q1 | $1.28B | Sell |
8,381,170
-16,719
| -0.2% | -$2.66M | 1.22% | 14 |
|
|
2013
Q4 | $1.12B | Sell |
8,397,889
-237,117
| -3% | -$28.5M | 1.1% | 20 |
|
|
2013
Q3 | $1B | Sell |
8,635,006
-1,023,542
| -11% | -$112M | 1.05% | 20 |
|
|
2013
Q2 | $891M | Buy |
+9,658,548
| New | +$931M | 1% | 26 |
|
Other funds holding ALXN
FCM
HI
DKCM
PCM
UOC